Adam Milstein Pushes Until His Ideas Become Realities

Adam Milstein made his way to the United States in 1981, and he set to work right away to get an education and start his career. This man is someone who is deeply involved in the lives of other Jewish individuals, and he is someone who is looking to make a difference in all that he does. Adam Milstein is a real estate investor, and the work that he does allows him to give his time and money to help others. He is a philanthropist who does his best to affect the world in a positive way.

There are some people who have the chance to complete different types of work each day of their lives. Adam Milstein has shared that no two days were the same for him when he first started working at his business. He shared that getting a business going requires a person to complete different work every day. There are some who choose to give of themselves and who find that their days are more exciting and fulfilling that way. Adam Milstein has shared that he started to enjoy each day of his life a little more once he got involved in causes that meant something to him.

It can be hard for a person to take the ideas that they have and make them a reality. Adam Milstein knows how hard that can be, and he has shared the secret that he has to making his ideas become realities. He shared that he pushes until those things that he wants to have come about truly do come about. He keeps working on an idea until it comes into being. Adam Milstein is someone who is ambitious enough to push and push until all of the ideas that he has become real. He does not give up.

Jim Tananbaum Shares His Success Thoughts.

For over 25 years, the world of healthcare has experienced phenomenal growth through the input of one scholar and entrepreneur, Jim Tananbaum. The Forbes-listed individual has been at the forefront of pushing for innovative and strategic growth of healthcare in the fields of

  • Healthcare
  • Genome sequencing
  • Bio-pharmaceuticals

In his push endeavors, Jim Tananbaum founded Foresite Capital, which is an equity venture firm dedicated to only healthcare-dedicated concepts and products. He has been according to deserving healthcare start-ups with necessary financial, strategic and operational assistance. Through such providences, some companies and firms, over 77 of them, have risen to operate profitably yet impacting the world positively. Some of the companies include,

  • 10x Genomics,
  • Intarcia Therapeutics,
  • Aerie Pharmaceuticals
  • and Aimmune Therapeutics.

In a recent interview that was conducted by INC42, Jim Tananbaum revealed some insightful methods that he employs to stay afloat of the dynamic and risky entrepreneurial world of bio-pharmaceuticals. He claimed that his biggest asset had been the time he spends peeking the minds of top players in his field of specialty. He attests that it is difficult to keep abreast of the dynamic and innovative pharmaceutical industry without ample knowledge and connections.

To Jim, investment takes more than just the mobilization of capital. Success cannot be bought or given. Individuals must have sufficient mastery of the operational needs of the business as well as a passion for doing things the right way. He attributed academic prowess and commitment to sustained efficiency in leadership in the science of preventing diseases. He revealed that he spends time reading and researching; that he always yearns to learn more.

He also acknowledged the power o persistence and resilience in amassing the wealth of expertise, reputation, and fiscal assets that he is worth today. To Jim Tananbaum, the only bad job is one that isn’t well done. He asserts that all jobs in the world are attractive to those with the passion for doing them and those put in coherent teams. A team without synergy fails to meet its objectives and subjects its members to frustration.

Jim Tananbaum is an avid entrepreneur and scholar. He is the co-founder of two of the world’s most innovative health-care firms in the world, GelTex Pharmaceuticals NASDAQ and, Theravance Biopharma, Inc. The two only, are worth 3.2 billion dollars. The healthcare sensation is also the founder and CEO of Foresite Capital.

See more:


Follow him on Twitter